GSE184892 trehalose fibroblast 0 v 2 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE184892_trehalose_fibroblast_0_v_2_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE184892_trehalose_fibroblast_0_v_2_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE184892_trehalose_fibroblast_0_v_2_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE184892_trehalose_fibroblast_0_v_2_human_up.

Results found

Linked to

 

Label

Description

 

Gene

HLA complex P5

Gene

embryonic stem cell related

Gene

solute carrier family 71 member 3, pseudogene

Gene

clustered mitochondria homolog pseudogene 3

Gene

PDCD6IP divergent transcript

Gene

cervical cancer associated DHX9 suppressive transcript

Gene

SLCO4A1 antisense RNA 1

Gene

uncharacterized LOC101927793

Gene

uncharacterized LOC101927888

Gene

KLHDC7B divergent transcript


  • Gene

    embryonic stem cell related


  • Gene

    solute carrier family 71 member 3, pseudogene


  • Gene

    clustered mitochondria homolog pseudogene 3


  • Gene

    PDCD6IP divergent transcript


  • Gene

    cervical cancer associated DHX9 suppressive transcript


  • Gene

    SLCO4A1 antisense RNA 1


  • Gene

    uncharacterized LOC101927793


  • Gene

    uncharacterized LOC101927888


  • Gene

    KLHDC7B divergent transcript

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.